Characterization of genetic changes in MCL by interphase FISH on tissue sections

Leukemia and Lymphoma

Volumn 48, Issue 7, 2007, Pages 1344-1352

  Sander, Birgitta ^a   Wallblom, Ann ^a   Ekroth, Andrea ^a   Porwit, Anna ^a   Kimby, Eva ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ATM; C myc; Cyclin D1 3'UTR; Interphase FISH; MCL; P16; P53; Proliferation

Indexed keywords

ATM PROTEIN; CYCLIN D1; MESSENGER RNA; MYC PROTEIN; PROTEIN P53;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; CYTOLOGY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE SECTION; TREATMENT OUTCOME;

ADULT; AGED; CELL CYCLE PROTEINS; CELL PROLIFERATION; CYCLIN D1; CYTOGENETIC ANALYSIS; DNA-BINDING PROTEINS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; MUTATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; SURVIVAL RATE; TRANSLOCATION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 34447578811     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701402903     Document Type: Article

References (44)

1. Remstein, E. D., Kurtin, P. J., Buno, I., Bailey, R. J., Proffitt, J. and Wyatt, W. A. (2000) Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma. Br J Haematol, 110, pp. 856-862.
2. Belaud-Rotureau, M. A., Parrens, M., Dubus, P., Garroste, J. C., de Mascarel, A. and Merlio, J. P. (2002) A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas. Mod Pathol, 15, pp. 517-525.
3. Rosenwald, A., Wright, G., Wiestner, A., Chan, W. C., Connors, J. M. and Campo, E. (2003) The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell, 3, pp. 185-197.
4. Stilgenbauer, S., Liebisch, P., James, M. R., Schroder, M., Schlegelberger, B. and Fischer, K. (1996) Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. Proc Natl Acad Sci USA, 93, pp. 11837-11841.
5. Monni, O., Zhu, Y., Franssila, K., Oinonen, R., Hoglund, P. and Elonen, E. (1999) Molecular characterization of deletion at 11q22.1-23.3 in mantle cell lymphoma. Br J Haematol, 104, pp. 665-671.
6. Stilgenbauer, S., Winkler, D., Ott, G., Schaffner, C., Leupolt, E. and Bentz, M. (1999) Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood, 94, pp. 3262-3264.
7. Cuneo, A., Bigoni, R., Rigolin, G. M., Roberti, M. G., Milani, R. and Bardi, A. (2000) Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features. J Clin Oncol, 18, pp. 2607-2614.
8. Schaffner, C., Idler, I., Stilgenbauer, S., Dohner, H. and Lichter, P. (2000) Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci USA, 97, pp. 2773-2778.
9. Decaudin, D. (2002) Mantle cell lymphoma: A biological and therapeutic paradigm. Leuk Lymphoma, 43, pp. 773-781.
10. Swerdlow, S. H. and Williams, M. E. (2002) From centrocytic to mantle cell lymphoma: A clinicopathologic and molecular review of 3 decades. Hum Pathol, 33, pp. 7-20.
11. Camacho, E., Hernandez, L., Hernandez, S., Tort, F., Bellosillo, B. and Bea, S. (2002) ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood, 99, pp. 238-244.
12. Greiner, T. C., Moynihan, M. J., Chan, W. C., Lytle, D. M., Pedersen, A. and Anderson, J. R. (1996) p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood, 87, pp. 4302-4310.
13. Weisenburger, D. D., Vose, J. M., Greiner, T. C., Lynch, J. C., Chan, W. C. and Bierman, P. J. (2000) Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am J Hematol, 64, pp. 190-196.
14. Dreyling, M. H., Bullinger, L., Ott, G., Stilgenbauer, S., Muller-Hermelink, H. K. and Bentz, M. (1997) Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Res, 57, pp. 4608-4614.
15. Pinyol, M., Hernandez, L., Cazorla, M., Balbin, M., Jares, P. and Fernandez, P. L. (1997) Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood, 89, pp. 272-280.
16. Hernandez, L., Bea, S., Pinyol, M., Ott, G., Katzenberger, T. and Rosenwald, A. (2005) CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus. Cancer Res, 65, pp. 2199-2206.
17. Au, W. Y., Horsman, D. E., Viswanatha, D. S., Connors, J. M., Klasa, R. J. and Gascoyne, R. D. (2000) 8q24 translocations in blastic transformation of mantle cell lymphoma. Haematologica, 85, pp. 1225-1227.
18. Nagy, B., Lundan, T., Larramendy, M. L., Aalto, Y., Zhu, Y. and Niini, T. (2003) Abnormal expression of apoptosis-related genes in haematological malignancies: Overexpression of MYC is poor prognostic sign in mantle cell lymphoma. Br J Haematol, 120, pp. 434-441.
19. Au, W. Y., Horsman, D. E., Gascoyne, R. D., Viswanatha, D. S., Klasa, R. J. and Connors, J. M. (2004) The spectrum of lymphoma with 8q24 aberrations: A clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma, 45, pp. 519-528.
20. Michaux, L., Wlodarska, I., Theate, I., Stul, M., Scheiff, J. M. and Deneys, V. (2004) Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: A rare finding associated with very poor outcome. Ann Hematol, 83, pp. 578-583.
21. Sander, B., Islam, T., Kimby, E., Smith, C IE and Christensson, B. (2002) American Society of Hematology abstracts. Blood
22. Islam, T. C., Asplund, A. C., Lindvall, J. M., Nygren, L., Liden, J. and Kimby, E. (2003) High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma. Leukemia, 17, pp. 1880-1890.
23. Sander, B., Flygare, J., Porwit-Macdonald, A., Smith, C. I., Emanuelsson, E. and Kimby, E. (2005) Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1. Int J Cancer, 117, pp. 418-430.
24. Raty, R., Franssila, K., Joensuu, H., Teerenhovi, L. and Elonen, E. (2002) Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma. Eur J Haematol, 69, pp. 11-20.
25. Bjorck, E., Porwit-MacDonald, A., Nordenskjold, M. and Borrebaeck, C. A. (2004) Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis. Haematologica, 89, pp. 686-695.
26. Tiemann, M., Schrader, C., Klapper, W., Dreyling, M. H., Campo, E. and Norton, A. (2005) Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): A clinicopathological study from the European MCL Network. Br J Haematol, 131, pp. 29-38.
27. Monni, O., Oinonen, R., Elonen, E., Franssila, K., Teerenhovi, L. and Joensuu, H. (1998) Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes Cancer, 21, pp. 298-307.
28. Bea, S., Ribas, M., Hernandez, J. M., Bosch, F., Pinyol, M. and Hernandez, L. (1999) Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood, 93, pp. 4365-4374.
29. Bentz, M., Plesch, A., Bullinger, L., Stilgenbauer, S., Ott, G. and Muller-Hermelink, H. K. (2000) t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer, 27, pp. 285-294.
30. Monni, O. and Knuutila, S. (2001) 11q deletions in hematological malignancies. Leuk Lymphoma, 40, pp. 259-266.
31. Greiner, T. C., Dasgupta, C., Ho, V. V., Weisenburger, D. D., Smith, L. M. and Lynch, J. C. (2006) Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma. Proc Natl Acad Sci USA, 103, pp. 2352-2357.
32. Hernandez, L., Fest, T., Cazorla, M., Teruya-Feldstein, J., Bosch, F. and Peinado, M. A. (1996) p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood, 87, pp. 3351-3359.
33. Cuneo, A., Bigoni, R., Rigolin, G. M., Roberti, M. G., Bardi, A. and Piva, N. (1999) Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features. Blood, 93, pp. 1372-1380.
34. Bigoni, R., Cuneo, A., Milani, R., Roberti, M. G., Bardi, A. and Rigolin, G. M. (2001) Secondary chromosome changes in mantle cell lymphoma: Cytogenetic and fluorescence in situ hybridization studies. Leuk Lymphoma, 40, pp. 581-590.
35. Solenthaler, M., Matutes, E., Brito-Babapulle, V., Morilla, R. and Catovsky, D. (2002) p53 and mdm2 in mantle cell lymphoma in leukemic phase. Haematologica, 87, pp. 1141-1150.
36. Sharpless, N. E. (2005) INK4a/ARF: A multifunctional tumor suppressor locus. Mutat Res, 576, pp. 22-38.
37. Hutter, G., Scheubner, M., Zimmermann, Y., Kalla, J., Katzenberger, T. and Hubler, K. (2006) Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma. Genes Chromosomes Cancer, 45, pp. 203-210.
38. Tirier, C., Zhang, Y., Plendl, H., Weber-Matthiesen, K., Langer, W. and Heit, W. (1996) Simultaneous presence of t(11;14) and a variant Burkitt's translocation in the terminal phase of a mantle cell lymphoma. Leukemia, 10, pp. 346-350.
39. Vaishampayan, U. N., Mohamed, A. N., Dugan, M. C., Bloom, R. E. and Palutke, M. (2001) Blastic mantle cell lymphoma associated with Burkitt-type translocation and hypodiploidy. Br J Haematol, 115, pp. 66-68.
40. Hao, S., Sanger, W., Onciu, M., Lai, R., Schlette, E. J. and Medeiros, L. J. (2002) Mantle cell lymphoma with 8q24 chromosomal abnormalities: A report of 5 cases with blastoid features. Mod Pathol, 15, pp. 1266-1272.
41. Thelander, E. F., Walsh, S. H., Thorselius, M., Laurell, A., Landgren, O. and Larsson, C. (2005) Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes. Mod Pathol, 18, pp. 331-339.
42. Martinez-Climent, J. A., Vizcarra, E., Sanchez, D., Blesa, D., Marugan, I. and Benet, I. (2001) Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma. Blood, 98, pp. 3479-3482.
43. Vizcarra, E., Martinez-Climent, J. A., Benet, I., Marugan, I., Terol, M. J. and Prosper, F. (2001) Identification of two subgroups of mantle cell leukemia with distinct clinical and biological features. Hematol J, 2, pp. 234-2341.
44. Rubio-Moscardo, F., Climent, J., Siebert, R., Piris, M. A., Martin-Subero, J. I. and Nielander, I. (2005) Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood, 105, pp. 4445-4454.